Sinovac Aztrazeneca Pfizer Moderna Cumulative

Sinovac Aztrazeneca Pfizer 1ST Moderna Sinovac Aztrazeneca Pfizer 2ND Moderna Janssen Cumulative Cumulative
PRIORITY_GROUP 1ST DOSE 1STDOSE DOSE 1ST DOSE 2ND DOSE 2ND DOSE DOSE 2ND DOSE One DOSE BOOSTER BOOSTER BOOSTER BOOSTER First Dose Complete Booster Dose
DOSE DOSE DOSE DOSE Dose
A1 264 52 34 9 264 48 39 11 37 4 40 106 17 359 399 167
A1.8 OFWs 4 3 12 9 7 6 18 10 21 - 2 12 3 28 62 17
A1.9 Family of HCWs 33 18 1 1 24 14 3 1 23 - 3 8 1 53 65 12
Additional A1 45 1 - 3 41 - - - 1 - - 2 - 49 42 2
A2 559 90 79 27 543 87 74 22 248 17 70 70 9 755 974 166
A3 Immunocompetent 45 8 - 54 8 20 2 378 3 62 102 10 53 462 177
Expanded A3 65 11 38 3 62 12 30 3 2 - 3 1 1 117 109 5
A4 1,755 1,059 1,368 183 1,616 810 1,241 175 525 6 67 237 17 4,365 4,367 327
A5 1,152 710 551 60 1,088 563 477 56 292 2 13 60 3 2,473 2,476 78
5-11 Pediatric A3 - - 134 - - - 28 - - - - - - 134 28 -
12-17 Pediatric A3 - - 7 - - - 3 - - - - - - 7 3 -
Rest of the Adult Population (ROAP) 68 59 171 3 46 53 131 4 87 2 8 26 2 301 321 38
5-11 Rest of Pediatric Population - - 1,357 - - - 773 - - - - - - 1,357 773 -
12-17 Rest of Pediatric Population - - 3,229 - - - 2,734 - - - - - - 3,229 2,734 -

3,990 2,011 6,981 298 3,745 1,601 5,571 284 1,614 34 268 624 63 13,280 12,815 989

PFIZER 5-11 2,292 1st Dose 13,280

PFIZER 12 YRS OLD AND ABOVE 10,884 Fully Vaccinated 12,815 35,594 36.00%
SINOVAC 7,769 Total Booster 989
MODERNA 645
AZTRAZENECA 3,880
JANSSEN 1,614
27,084 61%
 TABOGON RHU
COVID VACCINATION REPORT as of JULY 20, 2022

Sinovac Aztrazeneca Pfizer Moderna Pfizer 2nd Cumulative Cumulative

Sinovac Aztrazeneca Pfizer 1ST Moderna Sinovac Aztrazeneca Pfizer 2ND Moderna Janssen Cumulative Cumulative
PRIORITY_GROUP BOOSTER BOOSTER BOOSTER BOOSTER BOOSTER Complete 2nd Booster
1ST DOSE 1STDOSE DOSE 1ST DOSE 2ND DOSE 2ND DOSE DOSE 2ND DOSE One DOSE DOSE DOSE DOSE DOSE DOSE First Dose Dose Booster Dose Dose

A1 264 52 34 9 264 48 39 11 37 4 40 109 17 4 359 399 170 4

A1.8 OFWs 6 3 13 9 7 6 21 10 21 - 2 15 3 31 65 20 -
A1.9 Family of HCWs 33 18 1 1 24 14 3 1 23 - 3 8 1 53 65 12 -
Additional A1 45 1 - 3 41 - - - 1 - - 2 - 49 42 2 -
A2 559 90 81 27 543 87 75 22 248 17 70 71 9 6 757 975 167 6
A3 Immunocompetent 45 8 - 55 8 20 2 378 3 62 104 10 5 53 463 179 5
Expanded A3 65 11 38 3 63 12 31 3 2 - 3 1 1 117 111 5 -
A4 1,762 1,059 1,373 183 1,617 810 1,246 175 525 8 67 246 17 1 4,377 4,373 338 1
A5 1,152 710 551 60 1,090 563 482 56 292 5 13 68 3 2 2,473 2,483 89 2
5-11 Pediatric A3 - - 134 - - - 28 - - - - - - 134 28 - -
12-17 Pediatric A3 - - 7 - - - 3 - - - - - - 7 3 - -
Rest of the Adult Population (ROAP) 68 59 177 3 51 53 144 4 87 2 8 27 2 307 339 39 -
5-11 Rest of Pediatric Population - - 1,365 - - - 825 - - - - - - 1,365 825 - -
12-17 Rest of Pediatric Population - - 3,231 - - - 2,760 - - - - 2 - 3,231 2,760 2 -

3,999 2,011 7,005 298 3,755 1,601 5,677 284 1,614 39 268 653 63 18 13,313 12,931 1,023 18

PFIZER 5-11 2,352 1st Dose 13,313

PFIZER 12 YRS OLD AND ABOVE 11,001 Fully Vaccinated 12,931 35,594 36%
SINOVAC 7,793 Total Booster 1,041
MODERNA 645
AZTRAZENECA 3,880
JANSSEN 1,614
27,285
 COVID VACC

Sinovac Aztrazeneca Pfizer 1ST Moderna Sinovac

PRIORITY_GROUP 1ST DOSE 1STDOSE DOSE 1ST DOSE 2ND DOSE

A1 264 52 34 9 264
A1.8 OFWs 6 3 13 9 7
A1.9 Family of HCWs 33 18 1 1 24
Additional A1 45 1 - 3 41
A2 559 90 81 27 543
A3 Immunocompetent 45 8 - 55
Expanded A3 65 11 38 3 63
A4 1,765 1,059 1,373 183 1,619
A5 1,152 710 551 60 1,090
5-11 Pediatric A3 - - 134 - -
12-17 Pediatric A3 - - 7 - -
Rest of the Adult Population (ROAP) 68 59 178 3 52
5-11 Rest of Pediatric Population - - 1,380 - -
12-17 Rest of Pediatric Population - - 3,234 - -

4,002 2,011 7,024 298 3,758

PFIZER 5-11 2,392 1st Dose 13,335

PFIZER 12 YRS OLD AND ABOVE 11,030 Fully Vaccinated 12,972
SINOVAC 7,800 Total Booster 1,054
MODERNA 645
AZTRAZENECA 3,880
JANSSEN 1,614
27,361
 TABOGON RHU
COVID VACCINATION REPORT as of JULY 26, 2022

Sinovac Aztrazeneca Pfizer Moderna

Aztrazeneca Pfizer 2ND Moderna Janssen
2ND DOSE DOSE 2ND DOSE One DOSE BOOSTER BOOSTER BOOSTER BOOSTER
DOSE DOSE DOSE DOSE

48 39 11 37 4 40 109 17
6 21 10 21 - 2 15 3
14 3 1 23 - 3 8 1
- - - 1 - - 2 -
87 75 22 248 17 70 71 9
8 20 2 378 3 62 107 10
12 31 3 2 - 3 1 1
810 1,251 175 525 9 67 247 17
563 482 56 292 5 13 68 3
- 28 - - - - - -
- 3 - - - - - -
53 145 4 87 2 8 27 2
- 850 - - - - - -
- 2,767 - - - - 4 -

1,601 5,715 284 1,614 40 268 659 63

35,594 36%
Pfizer 2nd Cumulative Cumulative
Cumulative Cumulative
BOOSTER First Dose Complete Booster Dose 2nd Booster
DOSE Dose Dose

7 359 399 170 7

31 65 20 -
53 65 12 -
49 42 2 -
6 757 975 167 6
8 53 463 182 8
117 111 5 -
1 4,380 4,380 340 1
2 2,473 2,483 89 2
134 28 - -
7 3 - -
308 341 39 -
1,380 850 - -
3,234 2,767 4 -

24 13,335 12,972 1,030 24

 TABOGON RHU
COVID VACCINATION REPORT as of August 7, 2022

Sinovac Aztrazeneca Pfizer Moderna Pfizer 2nd Cumulative Cumulative

Sinovac Aztrazeneca Pfizer 1ST Moderna Sinovac Aztrazeneca Pfizer 2ND Moderna Janssen Cumulative Cumulative
PRIORITY_GROUP 1ST DOSE 1STDOSE DOSE 1ST DOSE 2ND DOSE 2ND DOSE DOSE 2ND DOSE One DOSE BOOSTER BOOSTER BOOSTER BOOSTER BOOSTER First Dose Complete Booster Dose 2nd Booster
DOSE DOSE DOSE DOSE DOSE Dose Dose

A1 264 52 34 9 264 48 39 11 37 4 40 109 17 7 359 399 170 7

A1.8 OFWs 6 3 13 9 7 6 21 10 21 - 2 15 3 31 65 20 -
A1.9 Family of HCWs 33 18 1 1 24 14 3 1 23 - 3 8 1 53 65 12 -
Additional A1 45 1 - 3 41 - - - 1 - - 2 - 49 42 2 -
A2 559 90 81 27 543 87 75 22 248 19 70 74 9 9 757 975 172 9
A3 Immunocompetent 46 8 - 55 8 20 2 378 4 62 111 10 10 54 463 187 10
Expanded A3 66 11 38 3 63 12 31 3 2 - 3 1 1 118 111 5 -
A4 1,765 1,059 1,378 183 1,619 810 1,251 175 525 10 67 249 17 1 4,385 4,380 343 1
A5 1,152 710 551 60 1,090 563 484 56 292 5 13 69 3 2 2,473 2,485 90 2
5-11 Pediatric A3 - - 134 - - - 28 - - - - - - 134 28 - -
12-17 Pediatric A3 - - 7 - - - 3 - - - - - - 7 3 - -
Rest of the Adult Population (ROAP) 68 59 178 3 52 53 148 4 87 3 8 27 2 308 344 40 -
5-11 Rest of Pediatric Population - - 1,380 - - - 850 - - - - - - 1,380 850 - -
12-17 Rest of Pediatric Population - - 3,235 - - - 2,769 - - - - 3 - 3,235 2,769 3 -

4,004 2,011 7,030 298 3,758 1,601 5,722 284 1,614 45 268 668 63 29 13,343 12,979 1,044 29

PFIZER 5-11 2,392 1st Dose 13,343

PFIZER 12 YRS OLD AND ABOVE 11,057 Fully Vaccinated 12,979 35,594 36%
SINOVAC 7,807 Total Booster 1,073
MODERNA 645
AZTRAZENECA 3,880 Remaining Vaccine:
JANSSEN 1,614 Moderna 41
27,395 Sinovac 113
Pfizer 2
 TABOGON RHU
COVID VACCINATION REPORT as of August 18, 2022

Sinovac Aztrazeneca Pfizer 1ST Moderna Sinovac Aztrazeneca Pfizer 2ND Moderna Janssen Sinovac Aztrazeneca Pfizer Moderna Pfizer 2nd Cumulative Cumulative Cumulative Cumulative
PRIORITY_GROUP BOOSTER BOOSTER BOOSTER BOOSTER BOOSTER Complete 2nd Booster
1ST DOSE 1STDOSE DOSE 1ST DOSE 2ND DOSE 2ND DOSE DOSE 2ND DOSE One DOSE DOSE DOSE DOSE DOSE DOSE First Dose Dose Booster Dose Dose

A1 264 52 34 9 264 48 39 11 37 4 40 113 17 8 359 399 174 8

A1.8 OFWs 6 3 13 9 7 6 23 10 21 - 2 1 3 31 67 6 -
A1.9 Family of HCWs 33 18 1 1 24 14 3 1 23 - 3 8 1 53 65 12 -
Additional A1 45 1 - 3 41 - - - 1 - - 2 - 49 42 2 -
A2 559 90 81 27 545 87 76 22 248 19 70 76 9 10 757 978 174 10
A3 Immunocompetent 47 8 - 55 8 20 2 378 5 62 115 10 11 55 463 192 11
Expanded A3 66 11 38 3 64 12 31 3 2 - 3 1 1 118 112 5 -
A4 1,771 1,059 1,383 183 1,622 810 1,257 175 525 13 67 268 17 5 4,396 4,389 365 5
A5 1,152 710 551 60 1,091 563 486 56 292 6 13 76 3 3 2,473 2,488 98 3
5-11 Pediatric A3 - - 134 - - - 28 - - - - - - 134 28 - -
12-17 Pediatric A3 - - 7 - - - 3 - - - - - - 7 3 - -
Rest of the Adult Population (ROAP) 72 59 179 3 53 53 154 4 87 3 8 28 2 313 351 41 -
5-11 Rest of Pediatric Population - - 1,414 - - - 912 - - - - - - 1,414 912 - -
12-17 Rest of Pediatric Population - - 3,242 - - - 2,795 - - - - 7 - 3,242 2,795 7 -

4,015 2,011 7,077 298 3,766 1,601 5,827 284 1,614 50 268 695 63 37 13,401 13,092 1,076 37

PFIZER 5-11 2,488 1st Dose 13,401 Remaining Vaccine:

PFIZER 12 YRS OLD AND ABOVE 11,148 Fully Vaccinated 13,092 35,594 37% Moderna 41
SINOVAC 7,831 1st Booster 1,076 Sinovac 94
MODERNA 645 2nd Booster 37 Pfizer 3
AZTRAZENECA 3,880 Pfizer 9
JANSSEN 1,614
27,606
 TABOGON RHU
COVID VACCINATION REPORT as of August 31, 2022

Sinovac Aztrazeneca Pfizer Moderna Pfizer 2nd Cumulative Cumulative

PRIORITY_GROUP Sinovac Aztrazeneca Pfizer 1ST Moderna Sinovac Aztrazeneca Pfizer 2ND Moderna Janssen BOOSTER BOOSTER BOOSTER BOOSTER BOOSTER Cumulative Complete Cumulative 2nd Booster
1ST DOSE 1STDOSE DOSE 1ST DOSE 2ND DOSE 2ND DOSE DOSE 2ND DOSE One DOSE First Dose Booster Dose
DOSE DOSE DOSE DOSE DOSE Dose Dose

A1 265 52 34 9 264 48 39 11 37 4 40 119 17 23 360 399 180 23

A1.8 OFWs 6 3 13 9 7 6 23 10 21 - 2 3 3 1 31 67 8 1
A1.9 Family of HCWs 33 18 1 1 24 14 3 1 23 - 3 9 1 2 53 65 13 2
Additional A1 45 1 - 3 41 - - - 1 - - 2 - 49 42 2 -
A2 559 90 85 27 545 87 76 22 248 19 70 82 9 17 761 978 180 17
A3 Immunocompetent 47 8 - 55 8 20 2 378 5 62 129 10 26 55 463 206 26
Expanded A3 66 11 38 3 66 12 32 3 2 - 3 1 1 118 115 5 -
A4 1,774 1,059 1,401 183 1,624 810 1,268 179 525 13 67 342 17 15 4,417 4,406 439 15
A5 1,153 710 552 60 1,092 563 488 56 292 7 13 96 3 5 2,475 2,491 119 5
5-11 Pediatric A3 - - 134 - - - 28 - - - - - - 134 28 - -
12-17 Pediatric A3 - - 7 - - - 3 - - - - - - 7 3 - -
Rest of the Adult Population (ROAP) 72 59 186 3 55 53 160 4 87 7 8 39 2 320 359 56 -
5-11 Rest of Pediatric Population - - 1,441 - - - 982 - - - - - - 1,441 982 - -
12-17 Rest of Pediatric Population - - 3,251 - - - 2,821 - - - - 20 - 3,251 2,821 20 -

4,020 2,011 7,143 298 3,773 1,601 5,943 288 1,614 55 268 842 63 89 13,472 13,219 1,228 89

PFIZER 5-11 2,585 1st Dose 13,472

PFIZER 12 YRS OLD AND ABOVE 11,432 Fully Vaccinated 13,219 35,594 37.14%
SINOVAC 7,848 1st Booster 1,228 30961 42.70%
MODERNA 649 2nd Booster 89
AZTRAZENECA 3,880
JANSSEN 1,614
TOTAL VACCINATED 28,008
 COVID VACCINA

Sinovac Aztrazeneca Pfizer 1ST Moderna Sinovac

PRIORITY_GROUP 1ST DOSE 1STDOSE DOSE 1ST DOSE 2ND DOSE

A1 266 52 34 9 264
A1.8 OFWs 6 3 14 9 7
A1.9 Family of HCWs 33 18 1 1 24
Additional A1 45 1 - 3 41
A2 568 90 90 27 546
A3 Immunocompetent 47 8 - 57
Expanded A3 66 11 40 3 68
A4 1,774 1,059 1,411 183 1,632
A5 1,153 710 553 60 1,094
5-11 Pediatric A3 - - 134 - -
12-17 Pediatric A3 - - 7 - -
Rest of the Adult Population (ROAP) 72 59 190 3 58
5-11 Rest of Pediatric Population - - 1,466 - -
12-17 Rest of Pediatric Population - - 3,258 - -

4,030 2,011 7,198 298 3,791

PFIZER 5-11 2,669 1st Dose 13,537

PFIZER 12 YRS OLD AND ABOVE 11,846 Fully Vaccinated 13,353
SINOVAC 7,882 1st Booster 1,493
MODERNA 649 2nd Booster 157
AZTRAZENECA 3,880
JANSSEN 1,614
TOTAL VACCINATED 28,540
 TABOGON RHU
COVID VACCINATION REPORT as of September 16, 2022

Sinovac Aztrazeneca Pfizer Moderna

Aztrazeneca Pfizer 2ND Moderna Janssen
2ND DOSE DOSE 2ND DOSE One DOSE BOOSTER BOOSTER BOOSTER BOOSTER
DOSE DOSE DOSE DOSE

48 41 11 37 4 40 137 17
6 23 10 21 - 2 7 3
14 3 1 23 - 3 10 1
- - - 1 - - 2 -
87 76 22 248 22 70 121 9
8 20 2 378 5 62 142 10
12 32 3 2 - 3 2 1
810 1,285 179 525 13 67 418 17
563 499 56 292 10 13 137 3
- 28 - - - - - -
- 3 - - - - - -
53 166 4 87 7 8 44 2
- 1,041 - - - - - -
- 2,842 - - - - 81 -

1,601 6,059 288 1,614 61 268 1,101 63

35,594 37.51%
30961 43.13%
Pfizer 2nd Cumulative Cumulative
Cumulative Cumulative
BOOSTER First Dose Complete Booster Dose 2nd Booster
DOSE Dose Dose

40 361 401 198 40

1 32 67 12 1
2 53 65 14 2
49 42 2 -
27 775 979 222 27
42 55 465 219 42
120 117 6 -
34 4,427 4,431 515 34
9 2,476 2,504 163 9
134 28 - -
7 3 - -
2 324 368 61 2
1,466 1,041 - -
3,258 2,842 81 -

157 13,537 13,353 1,493 157

 TABOGON RHU
COVID VACCINATION REPORT as of September 22, 2022

Sinovac Aztrazeneca Pfizer 1ST Moderna Sinovac Aztrazeneca Pfizer 2ND Moderna Janssen Sinovac Aztrazeneca Pfizer Moderna Pfizer 2nd Cumulative Cumulative Cumulative Cumulative
PRIORITY_GROUP BOOSTER BOOSTER BOOSTER BOOSTER BOOSTER Complete 2nd Booster
1ST DOSE 1STDOSE DOSE 1ST DOSE 2ND DOSE 2ND DOSE DOSE 2ND DOSE One DOSE DOSE DOSE DOSE DOSE DOSE First Dose Dose Booster Dose Dose

A1 266 52 35 9 264 48 41 11 37 4 40 139 17 43 362 401 200 43

A1.8 OFWs 6 3 14 9 7 6 23 10 21 - 2 8 3 1 32 67 13 1
A1.9 Family of HCWs 33 18 1 1 24 14 3 1 23 - 3 10 1 2 53 65 14 2
Additional A1 45 1 - 3 41 - - - 1 - - 2 - 49 42 2 -
A2 568 90 90 27 546 87 76 22 248 22 70 122 9 32 775 979 223 32
A3 Immunocompetent 47 8 - 57 8 20 2 378 5 62 142 10 42 55 465 219 42
Expanded A3 66 11 40 3 68 12 33 3 2 - 3 2 1 120 118 6 -
A4 1,775 1,059 1,413 183 1,633 810 1,288 179 525 13 67 430 17 35 4,430 4,435 527 35
A5 1,153 710 554 60 1,094 563 502 56 292 10 13 141 3 10 2,477 2,507 167 10
5-11 Pediatric A3 - - 134 - - - 28 - - - - - - 134 28 - -
12-17 Pediatric A3 - - 7 - - - 3 - - - - - - 7 3 - -
Rest of the Adult Population (ROAP) 72 59 192 3 59 53 167 4 87 7 8 52 2 3 326 370 69 3
5-11 Rest of Pediatric Population - - 1,470 - - - 1,050 - - - - - - 1,470 1,050 - -
12-17 Rest of Pediatric Population - - 3,259 - - - 2,845 - - - - 84 - 3,259 2,845 84 -

4,031 2,011 7,209 298 3,793 1,601 6,079 288 1,614 61 268 1,132 63 168 13,549 13,375 1,524 168

CATEGORY TARGET CURRENT PERFORM

PFIZER 5-11 2,682 1st Dose 13,549 A2 3,466 979 28.25%
PFIZER 12 YRS OLD AND ABOVE 11,906 Fully Vaccinated 13,375 35,594 37.58% ROPP 12-17 3,478 2,845 81.80%
SINOVAC 7,885 1st Booster 1,524 ROPP 5-11 4,230 1,050 24.82%
MODERNA 649 2nd Booster 168 BOOSTER 13,375 1,524 11.39%
AZTRAZENECA 3,880
JANSSEN 1,614
TOTAL VACCINATED 28,616
 TABOGON RHU
COVID VACCINATION REPORT as of September 30, 2022

Sinovac Aztrazeneca Pfizer Moderna Pfizer 2nd Cumulative Cumulative

PRIORITY_GROUP Sinovac Aztrazeneca Pfizer 1ST Moderna Sinovac Aztrazeneca Pfizer 2ND Moderna Janssen BOOSTER BOOSTER BOOSTER BOOSTER BOOSTER Cumulative Complete Cumulative 2nd Booster
1ST DOSE 1STDOSE DOSE 1ST DOSE 2ND DOSE 2ND DOSE DOSE 2ND DOSE One DOSE First Dose Booster Dose
DOSE DOSE DOSE DOSE DOSE Dose Dose

A1 266 52 36 9 264 48 42 11 37 5 40 187 17 61 363 402 249 61

A1.8 OFWs 6 3 14 9 7 6 23 10 21 - 2 11 3 1 32 67 16 1
A1.9 Family of HCWs 33 18 1 1 24 14 3 1 23 - 3 13 1 3 53 65 17 3
Additional A1 45 1 - 3 41 - - - 1 - - 2 - 49 42 2 -
A2 573 90 95 27 546 87 77 22 248 27 70 169 9 59 785 980 275 59
A3 Immunocompetent 47 8 4 - 57 8 21 2 378 5 62 154 10 64 59 466 231 64
Expanded A3 66 11 41 3 69 12 33 3 2 - 3 4 1 121 119 8 -
A4 1,779 1,059 1,425 183 1,637 810 1,312 179 525 18 67 583 17 69 4,446 4,463 685 69
A5 1,153 710 567 60 1,097 563 516 56 292 10 13 225 3 18 2,490 2,524 251 18
5-11 Pediatric A3 - - 134 - - - 28 - - - - - - 134 28 - -
12-17 Pediatric A3 - - 7 - - - 3 - - - - - - 7 3 - -
Rest of the Adult Population (ROAP) 73 59 200 3 62 53 174 4 87 7 8 71 2 5 335 380 88 5
5-11 Rest of Pediatric Population - - 1,498 - - - 1,110 - - - - - - 1,498 1,110 - -
12-17 Rest of Pediatric Population - - 3,267 - - - 2,873 - - - - 148 - 3,267 2,873 148 -

4,041 2,011 7,289 298 3,804 1,601 6,215 288 1,614 72 268 1,567 63 280 13,639 13,522 1,970 280

CATEGORY TARGET CURRENT PERFORM

PFIZER 5-11 2,770 1st Dose 13,639 A2 3,466 980 28.27%
PFIZER 12 YRS OLD AND ABOVE 12,581 Fully Vaccinated 13,522 35,594 37.99% ROPP 12-17 3,478 2,873 82.60%
SINOVAC 7,917 1st Booster 1,970 ROPP 5-11 4,230 1,110 26.24%
MODERNA 649 2nd Booster 280 1st BOOSTER 13,522 1,970 14.57%
AZTRAZENECA 3,880 2nd BOOSTER 1,970 280 14.21%
JANSSEN 1,614
TOTAL ADMINISTERED 29,411

NOTE: THE TARGET 35,594 IS 80.67% FROM THE TOTAL POPULATION

 TABOGON RHU
COVID VACCINATION REPORT as of October 7, 2022

Sinovac Aztrazeneca Pfizer 1ST Moderna Sinovac Aztrazeneca Pfizer 2ND Moderna Janssen Sinovac Aztrazeneca Pfizer Moderna Pfizer 2nd Cumulative Cumulative Cumulative Cumulative
PRIORITY_GROUP BOOSTER BOOSTER BOOSTER BOOSTER BOOSTER Complete 2nd Booster
1ST DOSE 1STDOSE DOSE 1ST DOSE 2ND DOSE 2ND DOSE DOSE 2ND DOSE One DOSE DOSE DOSE DOSE DOSE DOSE First Dose Dose Booster Dose Dose

A1 266 52 36 9 264 48 42 11 37 5 40 188 17 66 363 402 250 66

A1.8 OFWs 6 3 14 9 7 6 23 10 21 - 2 12 3 1 32 67 17 1
A1.9 Family of HCWs 33 18 1 1 24 14 3 1 23 - 3 13 1 3 53 65 17 3
Additional A1 45 1 - 3 41 - - - 1 - - 2 - 49 42 2 -
A2 573 90 96 27 546 87 77 22 248 27 70 171 9 59 786 980 277 59
A3 Immunocompetent 47 8 5 - 57 8 21 2 378 5 62 156 10 65 60 466 233 65
Expanded A3 66 11 41 3 69 12 33 3 2 - 3 4 1 121 119 8 -
A4 1,779 1,059 1,428 183 1,637 810 1,315 179 525 18 67 586 17 72 4,449 4,466 688 72
A5 1,153 710 567 60 1,097 563 516 56 292 10 13 226 3 18 2,490 2,524 252 18
5-11 Pediatric A3 - - 134 - - - 28 - - - - - - 134 28 - -
12-17 Pediatric A3 - - 7 - - - 3 - - - - - - 7 3 - -
Rest of the Adult Population (ROAP) 73 59 200 3 62 53 174 4 87 7 8 72 2 5 335 380 89 5
5-11 Rest of Pediatric Population - - 1,499 - - - 1,110 - - - - - - 1,499 1,110 - -
12-17 Rest of Pediatric Population - - 3,267 - - - 2,873 - - - - 148 - 3,267 2,873 148 -

4,041 2,011 7,295 298 3,804 1,601 6,218 288 1,614 72 268 1,578 63 289 13,645 13,525 1,981 289

CATEGORY TARGET CURRENT PERFORM

PFIZER 5-11 2,771 1st Dose 13,645 A2 3,466 980 28.27%
PFIZER 12 YRS OLD AND ABOVE 12,609 Fully Vaccinated 13,525 35,594 38.00% ROPP 12-17 3,478 2,873 82.60%
SINOVAC 7,917 1st Booster 1,981 ROPP 5-11 4,230 1,110 26.24%
MODERNA 649 2nd Booster 289 1st BOOSTER 13,525 1,981 14.65%
AZTRAZENECA 3,880 2nd BOOSTER 1,981 289 14.59%
JANSSEN 1,614
TOTAL ADMINISTERED 29,440

NOTE: THE TARGET 35,594 IS 80.67% FROM THE TOTAL POPULATION

 TABOGON RHU
COVID VACCINATION REPORT as of December 12, 2022

Sinovac Aztrazeneca Pfizer 1ST Moderna Sinovac Aztrazeneca Pfizer 2ND Moderna Janssen Sinovac Aztrazeneca Pfizer Moderna Pfizer 2nd Cumulative Cumulative Cumulative Cumulative
PRIORITY_GROUP BOOSTER BOOSTER BOOSTER BOOSTER BOOSTER Complete 2nd Booster
1ST DOSE 1STDOSE DOSE 1ST DOSE 2ND DOSE 2ND DOSE DOSE 2ND DOSE One DOSE DOSE DOSE DOSE DOSE DOSE First Dose Dose Booster Dose Dose

A1 266 52 37 9 264 48 43 11 37 5 40 197 17 77 364 403 259 77

A1.8 OFWs 6 3 14 9 7 6 24 10 21 - 2 18 3 3 32 68 23 3
A1.9 Family of HCWs 33 18 1 1 24 14 3 1 23 - 3 13 1 3 53 65 17 3
Additional A1 45 1 - 3 41 - - - 1 - - 2 - 49 42 2 -
A2 573 90 98 27 550 87 81 22 248 27 70 187 9 69 788 988 293 69
A3 Immunocompetent 47 8 5 - 57 8 21 2 378 6 62 162 10 71 60 466 240 71
Expanded A3 66 11 44 3 69 12 34 3 2 - 3 4 1 1 124 120 8 1
A4 1,779 1,059 1,437 183 1,639 810 1,328 179 525 18 67 667 17 96 4,458 4,481 769 96
A5 1,153 710 569 60 1,097 563 527 56 292 12 13 259 3 21 2,492 2,535 287 21
5-11 Pediatric A3 - - 134 - - - 28 - - - - - - 134 28 - -
12-17 Pediatric A3 - - 7 - - - 3 - - - - - - 7 3 - -
Rest of the Adult Population (ROAP) 73 59 207 3 62 53 179 4 87 8 8 91 2 7 342 385 109 7
5-11 Rest of Pediatric Population - - 1,520 - - - 1,143 - - - - - - 1,520 1,143 - -
12-17 Rest of Pediatric Population - - 3,280 - - - 2,898 - - - - 191 - 3,280 2,898 191 -

4,041 2,011 7,353 298 3,810 1,601 6,312 288 1,614 76 268 1,791 63 348 13,703 13,625 2,198 348

CATEGORY TARGET CURRENT PERFORM

PFIZER 5-11 2,825 1st Dose 13,703 A2 3,466 988 28.51%
PFIZER 12 YRS OLD AND ABOVE 12,979 Fully Vaccinated 13,625 35,594 38.28% ROPP 12-17 3,478 2,898 83.32%
SINOVAC 7,927 1st Booster 2,198 ROPP 5-11 4,230 1,143 27.02%
MODERNA 649 2nd Booster 348 1st BOOSTER 13,625 2,198 16.13%
AZTRAZENECA 3,880 2nd BOOSTER 2,198 348 15.83%
JANSSEN 1,614
TOTAL ADMINISTERED 29,874

NOTE: THE TARGET 35,594 IS 80.67% FROM THE TOTAL POPULATION

MUNICITY VACCINATION_DACREATE_DT CREATE_BVACCINE_BRAND
TABOGON 2022-12-07T00:02022-12-07T19:51:47.5 Rojas, F Pfizer
TABOGON 2022-12-07T00:02022-12-07T19:51:47.5 Rojas, F Pfizer
TABOGON 2022-12-07T00:02022-12-07T19:51:47.5 Rojas, F Pfizer
TABOGON 2022-12-07T00:02022-12-07T19:51:47.5 Rojas, F Pfizer
TABOGON 2022-12-07T00:02022-12-07T19:51:47.5 Rojas, F Pfizer
TABOGON 2022-12-07T00:02022-12-07T19:51:47.5 Rojas, F Pfizer
TABOGON 2022-12-07T00:02022-12-07T19:51:47.5 Rojas, F Pfizer
TABOGON 2022-12-07T00:02022-12-07T19:51:47.5 Rojas, F Pfizer
TABOGON 2022-12-06T00:02022-12-06T17:26:35.8 Rojas, F Sinovac Coronavac
TABOGON 2022-12-06T00:02022-12-06T17:26:35.8 Rojas, F Pfizer
TABOGON 2022-12-06T00:02022-12-06T17:26:35.8 Rojas, F Pfizer
TABOGON 2022-12-06T00:02022-12-06T17:26:35.8 Rojas, F Pfizer
TABOGON 2022-12-06T00:02022-12-06T17:26:35.8 Rojas, F Pfizer
TABOGON 2022-12-06T00:02022-12-06T17:26:35.8 Rojas, F Pfizer
TABOGON 2022-12-06T00:02022-12-06T17:26:35.8 Rojas, F Pfizer
TABOGON 2022-12-06T00:02022-12-06T17:26:35.8 Rojas, F Pfizer
TABOGON 2022-12-06T00:02022-12-06T17:26:35.8 Rojas, F Pfizer
TABOGON 2022-12-06T00:02022-12-06T17:26:35.8 Rojas, F Pfizer
TABOGON 2022-12-06T00:02022-12-06T17:26:35.8 Rojas, F Pfizer
TABOGON 2022-12-05T00:02022-12-05T17:45:33.7 Rojas, F Sinovac Coronavac
TABOGON 2022-12-05T00:02022-12-05T17:45:33.7 Rojas, F Pfizer
TABOGON 2022-12-05T00:02022-12-05T17:45:33.7 Rojas, F Pfizer
TABOGON 2022-12-05T00:02022-12-05T17:45:33.7 Rojas, F Pfizer
TABOGON 2022-12-05T00:02022-12-05T17:45:33.7 Rojas, F Pfizer
TABOGON 2022-12-05T00:02022-12-05T17:45:33.7 Rojas, F Pfizer
TABOGON 2022-12-05T00:02022-12-05T17:45:33.7 Rojas, F Pfizer
TABOGON 2022-12-05T00:02022-12-05T17:45:33.7 Rojas, F Pfizer
TABOGON 2022-12-05T00:02022-12-05T17:45:33.7 Rojas, F Pfizer
TABOGON 2022-12-05T00:02022-12-05T17:45:33.7 Rojas, F Pfizer
TABOGON 2022-12-04T00:02022-12-04T05:17:42.8 Rojas, F Pfizer
TABOGON 2022-12-04T00:02022-12-04T05:17:42.8 Rojas, F Pfizer
TABOGON 2022-12-03T00:02022-12-04T05:16:40.3 Rojas, F. Pfizer
TABOGON 2022-12-02T00:02022-12-04T05:14:58.9 Rojas, F Pfizer
TABOGON 2022-12-02T00:02022-12-04T05:14:58.9 Rojas, F Pfizer
TABOGON 2022-12-01T00:02022-12-04T05:13:46.4 Rojas, F Pfizer
TABOGON 2022-11-30T00:02022-05-04T00:56:56.2 CHD Janssen
TABOGON 2022-11-28T00:02022-11-29T13:19:18.9 Rojas, F Pfizer
TABOGON 2022-11-28T00:02022-11-29T13:19:18.9 Rojas, F Pfizer
TABOGON 2022-11-27T00:02022-11-28T09:47:51.4 Rojas, F Pfizer
TABOGON 2022-11-27T00:02022-11-28T09:47:51.4 Rojas, F Pfizer
TABOGON 2022-11-26T00:02022-11-28T14:23:17.0 Bachoco, Sinovac Coronavac
TABOGON 2022-11-25T00:02022-11-28T14:23:17.0 Bachoco, Sinovac Coronavac
TABOGON 2022-11-24T00:02022-11-25T09:43:21.6 Rojas, F Pfizer
TABOGON 2022-11-24T00:02022-11-25T09:43:21.6 Rojas, F Pfizer
TABOGON 2022-11-24T00:02022-11-25T09:43:21.6 Rojas, F Pfizer
TABOGON 2022-11-24T00:02022-11-25T09:43:21.6 Rojas, F Pfizer
TABOGON 2022-11-24T00:02022-11-25T09:43:21.6 Rojas, F Pfizer
TABOGON 2022-11-24T00:02022-11-25T09:43:21.6 Rojas, F Pfizer
TABOGON 2022-11-23T00:02022-11-25T09:37:18.9 Rojas, F Pfizer
TABOGON 2022-11-23T00:02022-11-25T09:37:18.9 Rojas, F Pfizer
TABOGON 2022-11-23T00:02022-11-25T09:37:18.9 Rojas, F Pfizer
TABOGON 2022-11-23T00:02022-11-25T09:37:18.9 Rojas, F Pfizer
TABOGON 2022-11-22T00:02022-11-25T09:32:10.2 Rojas, F Sinovac Coronavac
TABOGON 2022-11-22T00:02022-11-25T09:32:10.2 Rojas, F Sinovac Coronavac
TABOGON 2022-11-21T00:02022-11-25T09:27:35.0 Rojas, F Pfizer
TABOGON 2022-11-21T00:02022-11-25T09:27:35.0 Rojas, F Pfizer
TABOGON 2022-11-21T00:02022-11-25T09:27:35.0 Rojas, F Pfizer
TABOGON 2022-11-21T00:02022-11-25T09:27:35.0 Rojas, F Pfizer
TABOGON 2022-11-21T00:02022-11-25T09:27:35.0 Rojas, F Pfizer
TABOGON 2022-11-21T00:02022-11-25T09:27:35.0 Rojas, F Pfizer
TABOGON 2022-11-20T00:02022-11-21T08:15:45.5 Rojas, F Pfizer
TABOGON 2022-11-20T00:02022-11-21T08:15:45.5 Rojas, F Pfizer
TABOGON 2022-11-17T00:02022-11-18T05:21:25.8 Rojas. F Pfizer
TABOGON 2022-11-17T00:02022-11-18T05:21:25.8 Rojas. F Pfizer
TABOGON 2022-11-17T00:02022-11-18T05:21:25.8 Rojas. F Pfizer
TABOGON 2022-11-17T00:02022-11-18T05:21:25.8 Rojas. F Pfizer
TABOGON 2022-11-17T00:02022-11-18T05:21:25.8 Rojas. F Pfizer
TABOGON 2022-11-17T00:02022-11-18T05:21:25.8 Rojas. F Pfizer
TABOGON 2022-11-17T00:02022-11-18T05:21:25.8 Rojas. F Pfizer
TABOGON 2022-11-15T00:02022-11-18T05:15:15.3 Rojas, F. Sinovac Coronavac
TABOGON 2022-11-15T00:02022-11-18T05:15:15.3 Rojas, F. Pfizer
TABOGON 2022-11-15T00:02022-11-18T05:15:15.3 Rojas, F. Pfizer
TABOGON 2022-11-15T00:02022-11-18T05:15:15.3 Rojas, F. Pfizer
TABOGON 2022-11-15T00:02022-11-16T09:37:04.5 Rojas, F Pfizer
TABOGON 2022-11-15T00:02022-11-16T09:37:04.5 Rojas, F Pfizer
TABOGON 2022-11-15T00:02022-11-16T09:37:04.5 Rojas, F Pfizer
TABOGON 2022-11-15T00:02022-11-16T09:37:04.5 Rojas, F Pfizer
TABOGON 2022-11-15T00:02022-11-16T09:37:04.5 Rojas, F Pfizer
TABOGON 2022-11-15T00:02022-11-16T09:37:04.5 Rojas, F Pfizer
TABOGON 2022-11-15T00:02022-11-16T09:37:04.5 Rojas, F Pfizer
TABOGON 2022-11-14T00:02022-11-15T10:07:08.7 Rojas, F. Pfizer
TABOGON 2022-11-14T00:02022-11-15T10:07:08.7 Rojas, F. Pfizer
TABOGON 2022-11-14T00:02022-11-15T10:07:08.7 Rojas, F. Pfizer
TABOGON 2022-11-14T00:02022-11-15T10:07:08.7 Rojas, F. Pfizer
TABOGON 2022-11-14T00:02022-11-15T10:07:08.7 Rojas, F. Pfizer
TABOGON 2022-11-13T00:02022-11-15T09:58:59.4 Rojas, F Pfizer
TABOGON 2022-11-13T00:02022-11-15T09:58:59.4 Rojas, F Pfizer
TABOGON 2022-11-07T00:02022-11-08T14:20:20.5 Rojas, F Pfizer
TABOGON 2022-11-07T00:02022-11-08T14:20:20.5 Rojas, F Pfizer
TABOGON 2022-11-07T00:02022-11-08T14:20:20.5 Rojas, F Pfizer
TABOGON 2022-11-07T00:02022-11-08T14:20:20.5 Rojas, F Pfizer
TABOGON 2022-11-07T00:02022-11-08T14:20:20.5 Rojas, F Pfizer
TABOGON 2022-11-07T00:02022-11-08T14:20:20.5 Rojas, F Pfizer
TABOGON 2022-11-07T00:02022-11-08T14:20:20.5 Rojas, F Pfizer
TABOGON 2022-11-06T00:02022-11-04T10:53:25.8 ROJAS, F Pfizer
TABOGON 2022-11-05T00:02022-11-04T10:51:55.6 ROJAS, F Pfizer
TABOGON 2022-11-04T00:02022-11-04T10:49:23.4 ROJAS, F Pfizer
TABOGON 2022-11-03T00:02022-11-04T10:48:18.0 ROJAS, F Pfizer
TABOGON 2022-11-03T00:02022-11-04T10:48:18.0 ROJAS, F Pfizer
TABOGON 2022-11-03T00:02022-11-04T10:48:18.0 ROJAS, F Pfizer
TABOGON 2022-11-03T00:02022-11-04T10:48:18.0 ROJAS, F Pfizer
TABOGON 2022-11-03T00:02022-11-04T10:48:18.0 ROJAS, F Pfizer
TABOGON 2022-11-03T00:02022-11-04T10:48:18.0 ROJAS, F Pfizer
TABOGON 2022-11-03T00:02022-11-04T10:48:18.0 ROJAS, F Sinovac Coronavac
TABOGON 2022-11-02T00:02022-11-03T08:22:51.6 Rojas, F Pfizer
TABOGON 2022-11-02T00:02022-11-03T08:22:51.6 Rojas, F Pfizer
TABOGON 2022-11-01T00:02022-11-03T08:21:24.5 Rojas, F Sinovac Coronavac
TABOGON 2022-10-31T00:02022-11-01T10:21:44.0 Rojas, F Sinovac Coronavac
TABOGON 2022-10-30T00:02022-11-01T10:20:38.9 Rojas, F Sinovac Coronavac
TABOGON 2022-10-29T00:02022-11-08T15:09:20.0 Bachoco, Sinovac Coronavac
TABOGON 2022-10-28T00:02022-11-08T15:09:20.0 Bachoco, Sinovac Coronavac
TABOGON 2022-10-27T00:02022-11-08T15:08:10.4 Bachoco, Pfizer
TABOGON 2022-10-27T00:02022-11-08T15:08:10.4 Bachoco, Pfizer
TABOGON 2022-10-27T00:02022-11-08T15:08:10.4 Bachoco, Pfizer
TABOGON 2022-10-27T00:02022-11-08T15:08:10.4 Bachoco, Pfizer
TABOGON 2022-10-27T00:02022-11-08T15:08:10.4 Bachoco, Pfizer
TABOGON 2022-10-27T00:02022-11-08T15:08:10.4 Bachoco, Pfizer
TABOGON 2022-10-26T00:02022-10-27T10:38:57.2 Rojas, F Pfizer
TABOGON 2022-10-25T00:02022-10-26T09:56:09.8 Rojas, F Sinovac Coronavac
TABOGON 2022-10-25T00:02022-10-26T09:56:09.8 Rojas, F Sinovac Coronavac
TABOGON 2022-10-25T00:02022-10-26T09:56:09.8 Rojas, F Pfizer
TABOGON 2022-10-25T00:02022-10-26T09:56:09.8 Rojas, F Pfizer
TABOGON 2022-10-24T00:02022-10-26T09:53:28.4 Rojas, F Pfizer
TABOGON 2022-10-24T00:02022-10-26T09:53:28.4 Rojas, F Pfizer
TABOGON 2022-10-24T00:02022-10-26T09:53:28.4 Rojas, F Pfizer
TABOGON 2022-10-23T00:02022-10-26T09:50:33.1 Rojas, F Pfizer
TABOGON 2022-10-22T00:02022-11-08T15:08:10.4 Bachoco, Sinovac Coronavac
TABOGON 2022-10-21T00:02022-11-08T15:08:10.4 Bachoco, Sinovac Coronavac
TABOGON 2022-10-20T00:02022-10-21T16:09:13.8 Rojas, F Pfizer
TABOGON 2022-10-20T00:02022-10-21T16:09:13.8 Rojas, F Pfizer
TABOGON 2022-10-20T00:02022-10-21T16:09:13.8 Rojas, F Pfizer
TABOGON 2022-10-20T00:02022-10-21T16:09:13.8 Rojas, F Pfizer
TABOGON 2022-10-20T00:02022-10-21T16:09:13.8 Rojas, F Pfizer
TABOGON 2022-10-20T00:02022-10-21T16:09:13.8 Rojas, F Pfizer
TABOGON 2022-10-19T00:02022-10-21T16:04:18.3 Rojas, F Pfizer
TABOGON 2022-10-19T00:02022-10-21T16:04:18.3 Rojas, F Pfizer
TABOGON 2022-10-19T00:02022-10-21T16:04:18.3 Rojas, F Pfizer
TABOGON 2022-10-19T00:02022-10-21T16:04:18.3 Rojas, F Pfizer
 FIRST_D SECOND_ BOOSTER SECOND_
PRIORITY_GRP OSE DOSE _DOSE BOOSTER
5-11 Rest of Pediatric Population 3 4 0 0
12-17 Rest of Pediatric Population 2 4 4 0
Rest of the Adult Population (ROAP) 0 0 4 2
A5 0 1 1 0
A4 0 2 5 2
A3 Immunocompetent 0 0 0 1
A2 0 1 0 2
A1 0 0 0 1
A2 0 4 0 0
5-11 Rest of Pediatric Population 8 2 0 0
12-17 Rest of Pediatric Population 5 7 20 0
Rest of the Adult Population (ROAP) 3 1 3 0
A5 0 2 5 2
A4 1 1 10 11
Expanded A3 1 1 0 0
A3 Immunocompetent 0 0 1 1
A2 0 0 4 5
A1.8 OFWs 0 0 1 0
A1 0 0 4 5
A4 0 1 0 0
5-11 Rest of Pediatric Population 3 4 0 0
12-17 Rest of Pediatric Population 3 2 4 0
Rest of the Adult Population (ROAP) 0 1 1 0
A5 0 2 5 0
A4 4 3 11 1
Expanded A3 0 0 0 1
A3 Immunocompetent 0 0 1 2
A2 1 0 2 0
A1 1 0 0 2
A1.8 OFWs 0 0 0 0
A1 0 0 0 0
A1 0 0 0 0
A1 0 0 0 0
A1.8 OFWs 0 0 0 0
A4 1 0 0 0
A5 0 65 0 0
A1.8 OFWs 0 0 0 0
A1 0 0 0 0
A1.8 OFWs 0 0 0 0
A1 0 0 0 0
A3 Immunocompetent 0 0 0 0
A3 Immunocompetent 0 0 0 0
5-11 Rest of Pediatric Population 3 4 0 0
12-17 Rest of Pediatric Population 1 0 0 0
A5 0 1 1 0
A4 2 1 2 1
Expanded A3 2 0 0 0
A3 Immunocompetent 0 0 1 0
12-17 Rest of Pediatric Population 0 0 2 0
A5 0 0 3 0
A4 0 2 10 0
A2 0 0 0 1
A1.8 OFWs 0 0 0 0
A1 0 0 0 0
12-17 Rest of Pediatric Population 0 2 4 0
Rest of the Adult Population (ROAP) 0 0 3 0
A5 0 0 5 1
A4 0 0 6 0
A3 Immunocompetent 0 0 1 1
A2 0 0 1 0
A1.8 OFWs 0 0 0 0
A1 0 0 0 0
5-11 Rest of Pediatric Population 3 7 0 0
Rest of the Adult Population (ROAP) 0 0 1 0
12-17 Rest of Pediatric Population 0 2 0 0
A5 0 1 3 0
A4 0 0 3 4
A2 0 0 1 0
A1 0 0 2 1
A5 0 0 0 2
Rest of the Adult Population (ROAP) 0 0 1 0
A4 0 0 1 0
A1 0 0 0 1
12-17 Rest of Pediatric Population 1 3 1 0
Rest of the Adult Population (ROAP) 0 0 2 0
A5 0 1 4 0
A4 0 0 5 1
A2 1 0 0 0
A1.8 OFWs 0 0 0 1
A1 0 0 1 0
5-11 Rest of Pediatric Population 1 9 0 0
A5 0 0 1 0
A4 0 0 2 0
A2 0 0 4 0
A1.8 OFWs 0 0 1 1
A1.8 OFWs 0 0 0 0
A1 0 0 0 0
12-17 Rest of Pediatric Population 0 2 1 0
Rest of the Adult Population (ROAP) 1 0 1 0
A5 0 1 0 0
A4 0 1 5 1
A3 Immunocompetent 0 0 2 1
A2 0 0 0 1
A1 0 0 1 0
A1 0 0 0 0
A1 0 0 0 0
A1 0 0 0 0
12-17 Rest of Pediatric Population 1 1 0 0
Rest of the Adult Population (ROAP) 1 1 1 0
A5 2 1 2 0
A4 1 1 5 2
A2 0 3 0 0
A1.8 OFWs 0 0 1 0
A4 0 1 0 0
A4 0 0 2 0
A1.8 OFWs 0 0 2 0
A1 0 0 0 0
A1 0 0 0 0
A1 0 0 0 0
A3 Immunocompetent 0 0 0 0
A3 Immunocompetent 0 0 0 0
Rest of the Adult Population (ROAP) 0 1 0 0
A5 0 0 3 0
A4 0 1 1 0
A2 0 0 3 1
A1.8 OFWs 0 0 1 0
A1 0 0 0 1
A1 0 0 0 0
Rest of the Adult Population (ROAP) 0 0 1 0
A3 Immunocompetent 0 0 1 0
Rest of the Adult Population (ROAP) 1 1 0 0
A4 0 0 1 1
Rest of the Adult Population (ROAP) 1 0 0 0
A5 0 1 0 0
A1.8 OFWs 0 1 0 0
A1 0 0 0 0
A1 0 0 0 0
A1 0 0 0 0
A4 0 1 8 0
5-11 Rest of Pediatric Population 0 3 0 0
12-17 Rest of Pediatric Population 0 1 6 0
Rest of the Adult Population (ROAP) 0 0 1 0
A2 0 0 1 0
A1 0 0 1 0
12-17 Rest of Pediatric Population 0 1 0 0
Rest of the Adult Population (ROAP) 0 0 1 0
A4 0 0 1 0
A1 0 1 0 0
 TABOGON RHU
SVD PERFORMANCE

Sinovac Aztrazeneca Pfizer Moderna Pfizer 2nd Cumulative Cumulative

Sinovac Aztrazeneca Pfizer 1ST Moderna Sinovac Aztrazeneca Pfizer 2ND Moderna Janssen Cumulative Cumulative
PRIORITY_GROUP 1ST DOSE 1STDOSE DOSE 1ST DOSE 2ND DOSE 2ND DOSE DOSE 2ND DOSE One DOSE BOOSTER BOOSTER BOOSTER BOOSTER BOOSTER First Dose Complete Booster Dose 2nd Booster
DOSE DOSE DOSE DOSE DOSE Dose Dose

A1 1 1 1 48 18 1 1 49 18
A1.8 OFWs 3 - - 3 -
A1.9 Family of HCWs 1 3 1 1 - 3 1
Additional A1 - - - -
A2 6 4 1 6 47 27 10 1 53 27
A3 Immunocompetent 4 1 12 22 4 1 12 22
Expanded A3 1 1 2 1 1 2 -
A4 8 12 4 23 5 148 34 20 27 153 34
A5 13 4 14 83 8 13 18 83 8
5-11 Pediatric A3 - - - -
12-17 Pediatric A3 - - - -
Rest of the Adult Population (ROAP) 2 8 4 7 19 2 10 11 19 2
5-11 Rest of Pediatric Population 28 60 28 60 - -
12-17 Rest of Pediatric Population 8 28 64 8 28 64 -

17 - 79 - 13 - 135 - - 12 - 429 - 112 96 148 441 112

CATEGORY 1st Dose 2nd Dose 1st Booster 2nd Booster

PFIZER 5-11 88 1st Dose 96 A2 10 1 53 27
PFIZER 12 YRS OLD AND ABOVE 667 2ND Dose 148 ROPP 12-17 8 28 64
SINOVAC 42 1st Booster 441 ROPP 5-11 28 60
MODERNA - 2nd Booster 112
AZTRAZENECA -
JANSSEN -
TOTAL VACCINATED 797